tiprankstipranks
Advertisement
Advertisement

ENTX Stock Latest News

Entera Bio price target lowered to $9 from $10 at H.C. Wainwright
The FlyEntera Bio price target lowered to $9 from $10 at H.C. Wainwright
6d ago
ENTX
Entera Bio Announces $10 Million Private Placement Financing
PremiumCompany Announcements
Entera Bio Announces $10 Million Private Placement Financing
30d ago
8K
ENTX
Entera Bio Reports 2025 Results, Advances Oral Osteoporosis Pipeline
PremiumCompany Announcements
Entera Bio Reports 2025 Results, Advances Oral Osteoporosis Pipeline
1M ago
8K
ENTX
Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market
PremiumTipRanks Newswire
Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market
1M ago
LLY
ENTX
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
PremiumTipRanks Newswire
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
2M ago
CDXS
ENTX
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
PremiumTipRanks NewswireEntera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
2M ago
AZN
IBO
Entera Bio Submits Streamlined Phase 3 Plan for EB613
Premium
Company Announcements
Entera Bio Submits Streamlined Phase 3 Plan for EB613
2M ago
8K
ENTX
Entera Bio submits streamlined Phase 3 protocol to U.S. FDA for EB613
Premium
The Fly
Entera Bio submits streamlined Phase 3 protocol to U.S. FDA for EB613
2M ago
ENTX
Entera Bio Heads Toward Phase 3 With EB613 in a 200 Million-Woman Osteoporosis Market (NASDAQ: ENTX)
PremiumTipRanks Newswire
Entera Bio Heads Toward Phase 3 With EB613 in a 200 Million-Woman Osteoporosis Market (NASDAQ: ENTX)
2M ago
ENTX
Entera Bio announces open market purchases of stock by board members
PremiumThe Fly
Entera Bio announces open market purchases of stock by board members
3M ago
ENTX
Entera Bio Names Geno Germano Independent Board Chairman
PremiumCompany Announcements
Entera Bio Names Geno Germano Independent Board Chairman
3M ago
8K
ENTX
Entera Bio appoints Geno Germano as chairman of the board
PremiumThe Fly
Entera Bio appoints Geno Germano as chairman of the board
3M ago
PFE
ENTX
Entera Bio Expands OPKO Partnership, Adds New Director
PremiumCompany AnnouncementsEntera Bio Expands OPKO Partnership, Adds New Director
3M ago
8K
ENTX
Opko Health Entera Bio, Entera Bio expand partnership to advance PTH tablet
Premium
The Fly
Opko Health Entera Bio, Entera Bio expand partnership to advance PTH tablet
3M ago
OPK
ENTX
Entera Bio announces expected milestones for Q1 in 2026
Premium
The Fly
Entera Bio announces expected milestones for Q1 in 2026
3M ago
ENTX
Entera Bio ‘congratulates’ FNIH-ASBMR-SABRE team on FDA endpoint qualification
PremiumThe Fly
Entera Bio ‘congratulates’ FNIH-ASBMR-SABRE team on FDA endpoint qualification
4M ago
ENTX
Entera Bio announces new data on long-acting PTH tablet
PremiumThe Fly
Entera Bio announces new data on long-acting PTH tablet
4M ago
ENTX
Entera Bio Reports Q3 2025 Financial Results
PremiumCompany Announcements
Entera Bio Reports Q3 2025 Financial Results
5M ago
ENTX
Entera Bio Reports Q3 2025 Results and FDA Agreement
PremiumCompany Announcements
Entera Bio Reports Q3 2025 Results and FDA Agreement
6M ago
8K
ENTX
Entera Bio presents clinical data from EB613 Phase 2 trial
PremiumThe FlyEntera Bio presents clinical data from EB613 Phase 2 trial
6M ago
ENTX
Entera Bio’s Promising Oral Therapies Drive Buy Rating: Analyst Highlights Developments in GLP-2 and EB613 Programs
Premium
Ratings
Entera Bio’s Promising Oral Therapies Drive Buy Rating: Analyst Highlights Developments in GLP-2 and EB613 Programs
7M ago
ENTX
Entera Bio announces presentation of PK data for GLP-2 tablet treatment
Premium
The Fly
Entera Bio announces presentation of PK data for GLP-2 tablet treatment
8M ago
ENTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >